dibenzofuran-2-ylboronic acid

We are dibenzofuran-2-ylboronic acid CAS:402936-15-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:dibenzofuran-2-ylboronic acid
CAS.NO:402936-15-6
Synonyms:2-Dibenzofuranboronic acid
Dibenzo[b,d]furan-2-ylboronic acid
Molecular Formula:C12H9BO3
Molecular Weight:212.00900
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

dibenzofuran-2-ylboronic acid


Related News: Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.2-Bromo-5-fluorobenzotrifluoride CAS:40161-55-5 Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.Ácido 4-propil-3'-fluorobifenil-4'-borónico CAS:909709-42-8 This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.627-32-7 As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.

Related Products
Product Name
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate View Details
2,2-Dimethylbut-3-enoic acid View Details
Octadecyl isocyanate View Details
4,5-Diamino-1-(2-Hydroxy)Ethyl Pyrazole Sulfate manufacturer 1-Bromo-3-fluoro-4-iodobenzene manufacturer Palmitoyl Dipeptide-5 manufacturer 2-Hydroxy Phosphonoacetic Acid manufacturer N-([1,1′-biphenyl]-4-yl)-[1,1′-biphenyl]-2-amine manufacturer